Article
Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity.
Arthritis research & therapy - 1 Jan 2010
Accardo-Palumbo Antonina, Giardina Anna Rita, Ciccia Francesco, Ferrante Angelo, Principato Alfonso, Impastato Rosalia, Giardina Ennio, Triolo Giovanni
Abstract excerpt
INTRODUCTION: Infliximab is a chimeric monoclonal antibody against tumor necrosis factor alpha (TNF-alpha) that has been introduced recently for Behçet's disease (BD) patients who were resistant to standard treatment. The aim of this study was to analyse the functional changes of Vgamma9/Vdelta2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.